Michael R Filbin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Michael R Filbin

Showing results (71-80 of 73) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 73 results.

Biorxiv : the Preprint Server for Biology|November 11, 2020

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsMichael R Filbin, Arnav Mehta, Alexis M Schneider, et al.

Medrxiv : the Preprint Server for Health Sciences|December 3, 2025

A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunityKamil Slowikowski, Pritha Sen, Christopher V Cosgriff, et al.

JAMA|November 9, 2020

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical TrialWesley H Self, Matthew W Semler, Lindsay M Leither, et al.

Pageof 8

Search research articles

Showing results (71-80 of 73) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 73 results.

Biorxiv : the Preprint Server for Biology|November 11, 2020

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsMichael R Filbin, Arnav Mehta, Alexis M Schneider, et al.

Medrxiv : the Preprint Server for Health Sciences|December 3, 2025

A multimodal atlas of COVID-19 severity identifies hallmarks of dysregulated immunityKamil Slowikowski, Pritha Sen, Christopher V Cosgriff, et al.

JAMA|November 9, 2020

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: A Randomized Clinical TrialWesley H Self, Matthew W Semler, Lindsay M Leither, et al.

Pageof 8